natgillin/translations-raw huggingface dataset:
The active substance in Ribavirin BioPartners, ribavirin, is an antiviral belonging to the class ‘nucleoside analogues’.
Ravimi Ribavirin BioPartners toimeaine ribaviriin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in Ribavirin Mylan, ribavirin, is an antiviral belonging to the class ‘nucleoside analogues’.
Ravimi Ribavirin Mylan toimeaine ribaviriin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in Ribavirin Teva Pharma B.V., ribavirin, is an antiviral belonging to the class ‘nucleoside analogues’.
Ribavirin Teva Pharma B.V. toimeaine ribaviriin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in Ribavirin Teva, ribavirin, is an antiviral belonging to the class ‘nucleoside analogues’.
Ribavirin Teva toimeaine ribaviriin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in RILUTEK is riluzole which acts on the nervous system.
RILUTEK’i toimeaine on rilusool, mis toimib närvisüsteemi.
The active substance in Ristempa, pegfilgrastim, consists of filgrastim, which is very similar to a human protein called granulocyte colony stimulating factor (G-CSF), that has been ‘pegylated’ (attached to a chemical called polyethylene glycol).
Ristempa toimeaine pegfilgrastiim koosneb filgrastiimist – inimvalgu granulotsüütide kolooniat stimuleeriva faktori (G-CSF) koopiast –, mis on pegüleeritud (kaetud polüetüleenglükooliga (PEG)).
The active substance in Ruconest, conestat alfa, is a copy of the C1 esterase inhibitor protein and works in the same way as the natural human protein.
Ruconesti toimeaine alfakonestaat on C1-esteraasiinhibiitori koopia ja toimib samamoodi kui looduslik inimvalk.
The active substance in Sabervel, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Saberveli toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismis hormooni angiotensiin II toime.
The active substance in SANCUSO is granisetron.
SANCUSO sisaldab toimeainena granisetrooni.
The active substance in Sancuso, granisetron, is a ‘5HT3 antagonist’.
Sancuso toimeaine granisetroon on 5HT3-antagonist.
The active substance in Saxenda, liraglutide, is a ‘glucagon-like peptide-1 (GLP-1) receptor agonist’ that is already authorised in the EU as Victoza at lower doses (up to 1.8 mg per day) for the treatment of type 2 diabetes.
Saxenda toimeaine liraglutiid on glükagoonitaolise peptiid-1 (GLP-1) retseptori agonist, millel on juba Euroopa Liidus müügiluba ravimina Victoza, mis sisaldab toimeainet väiksemas annuses (kuni 1,8 mg ööpäevas), II tüüpi diabeedi raviks.
The active substance in Scenesse, afamelanotide, is similar to a hormone in the body known as alpha- melanocyte stimulating hormone, which stimulates the production of a brown-black pigment in the skin.
Scenesse toimeaine afamelanotiid sarnaneb organismiomase alfa-melanotsüüte stimuleeriva hormooniga, mis ergutab nahas värvipigmendi pruun ja must tootmist.
The active substance in Sebivo, telbivudine, is an antiviral medicine that belongs to the class ‘nucleoside analogues’.
Sebivo toimeaine telbivudiin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in Semintra, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Semintra toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Senshio, ospemifene, is a selective oestrogen receptor modulator (SERM).
Senshio toimeaine ospemifeen on selektiivne östrogeeni retseptori modulaator (selective oestrogen receptor modulator, SERM).
The active substance in Sevelamer carbonate Zentiva, sevelamer carbonate, is a phosphate binder.
Sevelamer carbonate Zentiva toimeaine sevelameerkarbonaat on fosfaate siduv aine.
The active substance in Silapo, epoetin zeta, is a copy of human erythropoietin and works in exactly the same way as the natural hormone to stimulate red blood cell production.
Silapo toimeaine dzeetaepoetiin on inimese erütropoetiini koopia ja toimib täpselt samamoodi kui looduslik hormoon, stimuleerides punaliblede teket.
The active substance in Sileo, dexmedetomidine hydrochloride, is a type of sedative medicine called an alpha-2 adrenoceptor agonist.
Sileo toimeaine deksmedetomidiinvesinikkloriid on rahusti alfa-2-adrenoretseptori agonist, mis pärsib organismi närvirakkudest neurotransmitteri noradrenaliini vabanemist.
The active substance in Simparica, sarolaner acts as an ‘ectoparasiticide’.
Simparica toimeaine sarolaneer toimib ektoparasititsiidina.
The active substance in SOMAVERT, pegvisomant is known as a growth hormone receptor antagonist.
SOMAVERT’i toimeainet pegvisomanti tuntakse kui kasvuhormooni retseptori antagonisti.
The active substance in SonoVue, sulphur hexafluoride, is a gas that is not soluble in the blood.
SonoVue toimeaine väävelheksafluoriid on veres lahustumatu gaas.
The active substance in Sovaldi, sofosbuvir, blocks the action of an enzyme called ‘NS5B RNA- dependent RNA polymerase’ in the hepatitis C virus, which is essential for the virus to multiply.
Sovaldi toimeaine sofosbuviir blokeerib C-hepatiidi viiruse paljunemisel osaleva ensüümi – NS5B RNAst sõltuva RNA-polümeraasi.
The active substance in Stayveer, bosentan, blocks a naturally occurring hormone called endothelin-1 (ET-1), which causes blood vessels to narrow.
Stayveeri toimeaine bosentaan blokeerib organismis tekkivat looduslikku hormooni endoteliin-1 (ET-1), mille mõjul veresooned ahenevad.
The active substance in Stocrin, efavirenz, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Stocrini toimeaine efavirens on mittenukleosiid-pöördtranskriptaasi inhibiitor (NNRTI), mis blokeerib ensüümi pöördtranskriptaasi toime.
The active substance in Strensiq can replace the missing enzyme (alkaline phosphatase) in hypophosphatasia.
Strensiqis sisalduv toimeaine võib hüpofosfataasia korral puuduvat ensüümi (leelisfosfataasi) asendada.
The active substance in Suprelorin, deslorelin, acts like the natural hormone gonadotropin- releasing hormone (GnRH) which controls the secretion of other hormones involved in fertility.
Suprelorini toimeaine desloreliin sarnaneb toime poolest loodusliku hormooni gonadotropiini vabastajahormooniga (GnRH), mis reguleerib muude viljakust määravate hormoonide eritumist.
The active substance in Sustiva, efavirenz, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Sustiva toimeaine efavirens on mittenukleosiid-pöördtranskriptaasi inhibiitor (NNRTI), mis blokeerib HIV-i tekitatava ensüümi pöördtranskriptaasi.
The active substance in Tafinlar, dabrafenib, works by blocking BRAF, a protein involved in stimulating cell division.
Tafinlari toimeaine dabrafeniib blokeerib rakkude jagunemise stimuleerimises osaleva BRAF-proteiini.
The active substance in Tagrisso, osimertinib, is a type of cancer medicine called tyrosine kinase inhibitor.
Tagrisso toimeaine osimertiniib on teatud tüüpi vähiravim, mida nimetatakse türosiinkinaasiinhibiitoriks.
The active substance in Tamiflu, oseltamivir, acts specifically on the flu virus, blocking some of the enzymes on its surface known as neuramidases.
Tamiflu toimeaine oseltamiviir toimib spetsiifiliselt gripiviiruse suhtes, blokeerides viirusepinna teatud ensüümid (neuraminidaasid).
The active substance in Tarceva, erlotinib, is a cancer medicine that belongs to the group ‘EGFR inhibitors’.
Tarceva toimeaine erlotiniib on EGFR-inhibiitorite rühma kuuluv vähiravim.
The active substance in Targretin, bexarotene, belongs to a group of medicines known as retinoids, which are related to vitamin A.
Targretin’i toimeaine beksaroteen kuulub ravimite klassi, mida nimetatakse retinoidideks ja mis on seotud A-vitamiiniga.
The active substance in Targretin, bexarotene, is an anticancer agent.
Targretinis toimeainena sisalduv beksaroteen on vähivastane aine.
The active substance in Taxotere, docetaxel, belongs to the group of anticancer medicines known as the taxanes.
Taxotere toimeaine dotsetakseel kuulub vähiravimite taksaanide rühma.
The active substance in Telmisartan Actavis, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Telmisartan Actavise toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismis hormooni angiotensiin II toime.
The active substance in Telmisartan Teva Pharma, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Telmisartan Teva Pharma toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismis hormooni angiotensiin II toime.
The active substance in Telmisartan Teva, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Telmisartan Teva toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismis hormooni angiotensiin II toime.
The active substance in Telzir, fosamprenavir, is a ‘prodrug’ of the protease inhibitor amprenavir, which means that it is converted into amprenavir in the body.
Telziri toimeaine fosamprenaviir on eelravim, mis muundub organismis proteaasiinhibiitoriks amprenaviiriks.
The active substance in Tepadina, thiotepa, belongs to a group of medicines called ‘alkylating agents’.
Tepadina toimeaine tiotepa kuulub alküülivate ainete ravimirühma.
The active substance in Thalidomide Celgene, thalidomide, is thought to work by blocking the development of cancer cells, and by stimulating some of the specialised cells of the immune system (the body’s defence mechanism) to attack the cancer cells.
Thalidomide Celgenes toimeainena sisalduva talidomiidi toime arvatakse seisnevat vähirakkude arenemise blokeerimises ning immuunsüsteemi (organismi kaitsemehhanismi) teatavate rakkude stimuleerimises vähirakke ründama.
The active substance in the product is an analogue of gonadotropin releasing factor (GnRF) linked to a carrier protein obtained from the bacterium Corynebacterium diphtheriae.
Toote toimeaine on gonadotropiini vabastava faktori (GnRF) analoog, mis on kinnitunud bakterist Corynebacterium diphtheria saadud kandevalgule.
The active substance in this medicine helps your body to increase the production of insulin when your blood sugar is high.
Selles ravimis sisalduv toimeaine aitab teie organismil insuliini tootmist suurendada, kui teie veresuhkru tase on kõrge.
The active substance in this medicine is sucroferric oxyhydroxide (also known as mixture of polynuclear iron(III)-oxyhydroxide, sucrose (sugar) and starches).
Selle ravimi toimeaine on sahharo-raud(III)oksühüdroksiid (tuntud ka polünukleaarse raud(III)- oksühüdroksiidi, sahharoosi ja tärkliste seguna).
The active substance in Thorinane, enoxaparin, is one of a group of anticoagulant medicines called ‘low-molecular weight heparins’.
Thorinane toimeaine enoksapariin on antikoagulant, mis kuulub madalmolekulaarsete hepariinide rühma.
The active substance in Tobi Podhaler, tobramycin, is an antibiotic that belongs to the group ‘aminoglycosides’.
Tobi Podhaleri toimeaine tobramütsiin on aminoglükosiidide rühma kuuluv antibiootikum.
The active substance in Tolura, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Tolura toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Topotecan Actavis, topotecan, is an anticancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Topotecan Actavise toimeaine topotekaan on topoisomeraasiinhibiitorite rühma kuuluv vähiravim.
The active substance in Topotecan Eagle, topotecan, is an anticancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Topotecan Eagle toimeaine topotekaan on topoisomeraasiinhibiitorite rühma kuuluv vähiravim.
The active substance in Topotecan Hospira, topotecan, is an anticancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Topotecan Hospira toimeaine topotekaan on topoisomeraasiinhibiitorite rühma kuuluv vähiravim.
The active substance in Topotecan Teva, topotecan, is an anticancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Topotecan Teva toimeaine topotekaan on topoisomeraasiinhibiitorite rühma kuuluv vähiravim.
The active substance in Torisel, temsirolimus, is an anticancer medicine, which acts by blocking a protein called ‘mammalian target of rapamycin’ (mTOR).
Toriseli toimeaine temsiroliimus on vähiravim, mille toime seisneb valgu mTOR (imetajate rapamütsiinisihtvalk) blokeerimises.
The active substance in Toujeo, insulin glargine, is slightly different from human insulin.
Toujeo toimeaine glargiininsuliin erineb veidi iniminsuliinist.
The active substance in Tracleer, bosentan, blocks a naturally occurring hormone called endothelin-1 (ET-1), which causes blood vessels to narrow.
Tracleeri toimeaine bosentaan blokeerib loodusliku hormooni endoteliin-1 (ET1), mis ahendab veresooni.
The active substance in Trisenox, arsenic trioxide, is a chemical that has been used in medicines for many years, including for the treatment of leukaemia.
Trisenoxi toimeaine arseentrioksiid on kemikaal, mida on ravimites, sealhulgas leukeemiaravimites kasutatud mitu aastat.
The active substance in Trocoxil, mavacoxib, belongs to a class of medicines called non steroidal anti- inflammatory drugs (NSAIDs).
Trocoxili toimeaine mavakoksiib kuulub mittesteroidsete põletikuvastasteks ravimite rühma.
The active substance in Trulicity, dulaglutide, is a ‘GLP-1 receptor agonist’.
Trulicity toimeaine dulaglutiid on GLP-1 retseptori agonist.
The active substance in Tygacil, tigecycline, belongs to a group of antibiotics called ‘glycylcyclines’.
Tygacili toimeaine tigetsükliin kuulub antibiootikumide glütsüültsükliinide rühma.
The active substance in Tyverb is lapatinib.
Tyverb’i toimeaine on lapatiniib.
The active substance in Uptravi, selexipag, is a ‘prostacyclin receptor agonist’.
Uptravi toimeaine seleksipaag on prostatsükliini retseptori agonist.
The active substance in Vantobra, tobramycin, belongs to the group of antibiotics known as ‘aminoglycosides’.
Vantobra toimeaine tobramütsiin kuulub aminoglükosiid-antibiootikumide rühma.
The active substance in Vedrop, tocofersolan, is vitamin E that has been made water soluble by attaching it to a chemical called polyethylene glycol.
Vedropi toimeaine tokofersolaan on E-vitamiin, mis lahustub vees seetõttu, et sellele on lisatud polüetüleenglükooli.
The active substance in Veraflox, pradofloxacin, belongs to a group of antibiotics called ‘fluoroquinolones’.
Verafloxi toimeaine pradofloksatsiin on fluorokinoloonide hulka kuuluv antibiootikum.
The active substance in Vfend, voriconazole, belongs to the ‘triazole’ class of antifungal medicines.
Vfendi toimeaine vorikonasool kuulub seentevastaste ravimite triasoolide klassi.
The active substance in Vibativ, telavancin, is an antibiotic that belongs to the group ‘glycopeptides’.
Vibativi toimeaine telavantsiin on glükopeptiidide rühma kuuluv antibiootikum.
The active substance in Vidaza, azacitidine, belongs to the group ‘anti-metabolites’.
Vidaza toimeaine asatsitidiin kuulub antimetaboliitide rühma.
The active substance in Vimpat, lacosamide, is an anti-epileptic medicine.
Vimpati toimeaine lakosamiid on epilepsiaravim.
The active substance in Viracept is nelfinavir.
Viracept’is sisalduv toimeaine on nelfinaviir.
The active substance in Viraferon, interferon alfa-2b, belongs to the group ‘interferons’.
Viraferonis toimeainena sisalduv alfa-2b-interferoon kuulub interferoonide rühma.
The active substance in ViraferonPeg, peginterferon alfa-2b, belongs to the group ‘interferons’.
ViraferonPegi toimeaine alfa-2b-peginterferoon kuulub interferoonide rühma.
The active substance in Viread, tenofovir disoproxil, is a ‘prodrug’ that is converted into tenofovir in the body.
Vireadi toimeaine tenofoviirdisoproksiil on eelravim, mis muundub organismis tenofoviiriks.
The active substance in Vistide, cidofovir, is an antiviral medicine that belongs to the class ‘nucleotide analogues’.
Vistides toimeainena sisalduv tsidofoviir on nukleotiidianaloogide klassi kuuluv viiruseravim.
The active substance in Volibris, ambrisentan, blocks the receptors for a hormone called endothelin, which causes blood vessels to constrict.
Volibrises toimeainena sisalduv ambrisentaan blokeerib veresoonte kokkutõmbumist põhjustava hormooni endoteliini retseptoreid.
The active substance in Voriconazole Accord, voriconazole, is an antifungal medicine that belongs to the ‘triazole’ group.
Voriconazole Accordi toimeaine vorikonasool on triasoolide rühma kuuluv seenevastane ravim.
The active substance in Voriconazole Hospira, voriconazole, belongs to the ‘triazole’ class of antifungal medicines.
Voriconazole Hospira toimeaine vorikonasool kuulub seenevastaste ravimite triasoolide klassi.
The active substance in Votrient is pazopanib (as hydrochloride).
Toimeaine on pasopaniib (vesinikkloriidina).
The active substance in Votubia, everolimus, is an anti-tumour medicine that acts by blocking an enzyme called ‘mammalian target of rapamycin’ (mTOR), which has increased activity in tumour cells of patients with SEGA or renal angiomyolipoma.
Votubia toimeaine everoliimus on kasvajavastane aine, mis blokeerib ensüümi mTOR (imetajate rapamütsiinsihtvalk), mille aktiivsus on subependümaalse hiidrakulise astrotsütoomiga või renaalse angiomüolipoomiga patsientide kasvajarakkudes suurenenud.
The active substance in Wakix, pitolisant, works by attaching to receptors in the brain called ‘histamine H3 receptors’.
Wakixi toimeaine pitolisant seondub peaajus histamiin H3 retseptoritega.
The active substance in Xadago, safinamide, is a ‘monoamine oxidase-B (MAO-B) inhibitor’.
Xadago toimeaine safinamiid on monoaminoksüdaas-B (MAO-B) inhibiitor.
The active substance in Xeloda, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti metabolites’.
Xeloda toimeaine kapetsitabiin on antimetaboliitide rühma kuuluv tsütotoksiline ravim (ravim, mis hävitab poolduvaid rakke, näiteks vähirakke).
The active substance in Xiapex is collagenase clostridium histolyticum, and this collagenase is produced using the microorganism Clostridium histolyticum.
Xiapexi toimeaine on Clostridium histolyticum’i kollagenaas ja selle kollagenaasi tootmiseks kasutatakse mikroorganismi Clostridium histolyticum.
The active substance in Xigris, drotrecogin alfa (activated), is very similar to a natural anticoagulant found in the body called activated protein C. Drotrecogin alfa is produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce drotrecogin alfa.
Xigrise toimeaine aktiveeritud alfadrotrekogiin on väga sarnane organismis sisalduvale looduslikule antikoagulandile aktiveeritud proteiinile C. Alfadrotrekogiini valmistatakse rekombinant-DNA-tehnika abil: seda toodab rakk, millele on lisatud alfadrotrekogiini teket võimaldav geen (DNA).
The active substance in Xtandi, enzalutamide, works by blocking the action of the male hormone testosterone and other male hormones known as androgens.
Xtandi toimeaine ensalutamiidi toime seisneb meessuguhormooni testosterooni ja teiste meessuguhormoonide androgeenide toime blokeerimises.
The active substance in Yellox, bromfenac, is a non-steroidal anti-inflammatory drug (NSAID).
Yelloxi toimeaine bromofenakk on mittesteroidne põletikuvastane ravim.
The active substance in Yervoy, ipilimumab, is a monoclonal antibody.
Yervoy toimeaine ipilimumaab on monoklonaalne antikeha.
The active substance in Yondelis, trabectedin, is a synthetic version of a substance that was originally extracted from a species of tunicate or ‘sea squirt’ (a marine animal).
Yondelise toimeaine trabektediin on mantelloomadest (teatud mereloomad) eraldatud aine sünteetiline analoog.
The active substance in ZACTRAN 150 mg/ml solution for injection for cattle and pigs is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
ZACTRAN 150 mg/ml süstelahuse veistele aktiivne toimeaine on lisatud komisjoni määruse (EL) nr 37/2010 lisa tabelisse 1 järgmiselt:
The active substance in Zebinix, eslicarbazepine acetate, is converted into the anti-epileptic medicine eslicarbazepine in the body.
Zebinixi toimeaine eslikarbatsepiinatsetaat muundub organismis epilepsiaravimiks eslikarbatsepiiniks.
The active substance in Zeffix, lamivudine, is an antiviral agent that belongs to the class ‘nucleoside analogues’.
Zeffixi toimeaine lamivudiin on nukleosiidianaloogide klassi kuuluv viiruseravim.
The active substance in Zerene, zaleplon, belongs to a group of medicines that are related to the benzodiazepines.
Zerenes toimeainena sisalduv zaleploon kuulub bensodiasepiinidega seotud ravimite rühma.
The active substance in Zinbryta, daclizumab, is a monoclonal antibody that attaches to T cells.
Zinbrytas toimainena sisalduv daklitsumaab on T- rakkudega seonduv monoklonaalne antikeha.
The active substance in Zoledronic Acid Accord, zoledronic acid, is a bisphosphonate.
Zoledronic Acid Accordi toimeaine soledroonhape on bisfosfonaat.
The active substance in Zoledronic acid Actavis is zoledronic acid, which belongs to a group of substances called bisphosphonates.
Zoledronic acid Actavis’e toimeaine on zoledroonhape, mis kuulub bisfosfonaatideks nimetatud ravimite rühma.
The active substance in Zoledronic acid Mylan is zoledronic acid, which belongs to a group of substances called bisphosphonates.
Zoledronic acid Mylan’i toimeaine on zoledroonhape, mis kuulub bisfosfonaatideks nimetatud ravimite rühma.
The active substance in ZOLVIX is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Toimeaine ZOLVIX on on Komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 kirjeldatud lubatud aine:
The active substance in Zonegran is zonisamide.
Zonegran sisaldab toimeainena zonisamiidi.
The active substance in Zuprevo is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zuprevo on komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 kirjeldatud lubatud aine(d):
The active substance in Zyclara cream, imiquimod, is an immune response modifier.
Zyclaras toimeainena sisalduv imikvimood on immuunvastuse modulaator.
The active substance in Zydelig, idelalisib, blocks the effects of an enzyme called PI3K-delta.
Zydeligi toimeaine idelalisiib blokeerib ensüümi PI3K-delta toimed.
The active substance in Zykadia, ceritinib, works by blocking the activity of ALK, thereby reducing the growth and spread of the cancer.
Zykadia toimeaine tseritiniib blokeerib ALKi toime, aeglustades nii vähi kasvamist ja levimist.
The active substance in Zytiga, abiraterone acetate, is changed in the body to abiraterone which stops the body from producing testosterone, a male hormone.
Zytiga toimeaine abirateroonatsetaat muundub organismis abiraterooniks, mis peatab meessuguhormooni testosterooni tekkimise organismis.
The active substance is 1.5 mg fondaparinux sodium in 0.3 ml solution for injection
Toimeaine on 1,5 mg fondapariinuksnaatriumi 0,3 ml süstelahuses.
The active substance is 1.5 mg fondaparinux sodium in 0.3 ml solution for injection
Toimeaine on 1,5 mg naatriumfondapariinuksit 0,3 ml süstelahuses.
The active substance is 13C-urea.
Toimeaine on 13C-uurea.
The active substance is 2.5 mg fondaparinux sodium in 0.5 ml solution for injection
Toimeaine on 2,5 mg fondapariinuksnaatriumi 0,5 ml süstelahuses.
The active substance is 2.5 mg fondaparinux sodium in 0.5 ml solution for injection
Toimeaine on 2,5 mg naatriumfondapariinuksit 0,5 ml süstelahuses.
The active substance is 30 mg of iron as ferric maltol.
Toimeaine on 30 mg rauda raud(III)maltoolina.
The active substance is 5 mg desloratadine.
Toimeaine on desloratadiin (5 mg).
The active substance is 5-aminolaevulinic acid (as hydrochloride).
Toimeaine on 5-aminolevuliinhape (vesinikkloriidina).
The active substance is :
Toimeaine on: